首页> 外国专利> VACCINE AND THERAPEUTIC COMPOSITION AGAINST FOR GALLIBACTERIUM ANATIS INFECTION

VACCINE AND THERAPEUTIC COMPOSITION AGAINST FOR GALLIBACTERIUM ANATIS INFECTION

机译：肛门菌感染的疫苗和治疗成分

页面导航

摘要
著录项
相似文献

摘要

The invention Galicia tumefaciens Ana tooth vaccine composition comprising GtxA-N, using the vaccine composition solidifying immune birds, and how to produce GtxA-N-specific IgY antibodies from serum or egg yolk of the immunized bird the N-GtxA the administration of specific IgY antibodies to the birds, to a method for treating or preventing Galicia tumefaciens Ana tooth infection.

机译：本发明的包含GtxA-N的根瘤菌疫苗组合物，其使用该疫苗组合物固化免疫鸟，以及如何从被免疫鸟的血清或蛋黄中产生GtxA-N特异性IgY抗体，N -GtxA：向禽类施用特定的IgY抗体，以治疗或预防 Galicia tumefaciens Ana牙感染的方法。 展开▼

著录项

公开/公告号KR20200081141A

专利类型

公开/公告日2020-07-07

原文格式PDF

申请/专利权人 제주대학교 산학협력단;
展开▼

申请/专利号KR20180171316

发明设计人 정동기;장 지오지오;
展开▼

申请日2018-12-27

分类号A61K39/102;A61K39;A61P31/04;

国家 KR

入库时间 2022-08-21 11:06:33

相似文献

专利

外文文献

中文文献

1. 治疗和预防幽门螺杆菌感染的重组融合蛋白疫苗及减毒活菌载体疫苗 [P] . 中国专利： CN101905018B . 2013.04.24

2. 治疗和预防幽门螺杆菌感染的重组融合蛋白疫苗及减毒活菌载体疫苗 [P] . 中国专利： CN101905018A . 2010-12-08

3. VACCINE AND THERAPEUTIC COMPOSITION AGAINST FOR GALLIBACTERIUM ANATIS INFECTION [P] . 韩国专利： KR1020200081141A . 2020.07.07

4. THERAPEUTIC VACCINE COMPOSITIONS INDUCING TOLERANCE TO HIV FOR TREATING HIV INFECTIONS IN HUMANS [P] . 世界知识产权组织专利： WO2012137072A1 . 2012-10-11

机译：治疗性疫苗成分可诱导对HIV的耐受性，从而治疗人类的HIV感染

5. Methods for extracting or inducing, in a mammal, a parasite-directed immune response, to treat a mammal for parasitic infection therapeutically or prophylactically, for the treatment and / or prophylaxis of an unhealthy mammalian condition, use of a composition, composition, vaccine composition, pharmaceutical composition, antibody for inhibiting, stopping or delaying the onset or progression of an unhealthy mammalian condition, use of an antibody, methods for detecting an immunoreactive molecule directed at a microorganism in a biological sample and to detect, monitor or otherwise evaluate an immune response directed to a microorganism in an individual, modular kit, method for analyzing, designing and / or modifying an agent capable of interacting with an anti-gpi glycan immunointeractive molecule binding site. , and, agent use [P] . BR0312985A . 2005-06-21

机译：组合物，组合物，疫苗组合物的用途，用于在哺乳动物中提取或诱导针对寄生虫的免疫应答，以治疗性或预防性地治疗哺乳动物以治疗寄生虫感染，用于治疗和/或预防不健康的哺乳动物疾病。，药物组合物，用于抑制，阻止或延迟不健康哺乳动物疾病的发作或发展的抗体，抗体的用途，用于检测针对生物样品中微生物的免疫反应性分子并检测，监测或评估免疫的方法在单独的模块化试剂盒中针对微生物的响应进行分析，设计和/或修饰能够与抗gpi聚糖免疫相互作用分子结合位点相互作用的试剂的方法。和代理商使用

1. Overview of an Emerging Coronavirus Infection, COVID-19: Current Status of Vaccine Development and Therapeutics [J] . Md. Sohel Rana, Md. Maruf Hasan, Md. Eshak Enan, 药理与制药（英文） . 2021,第001期

2. HBsAg, HBcAg, and combined HBsAg/HBcAg-based therapeutic vaccines in treating chronic hepatitis B virus infection [J] . Sheikh Mohammad Fazle Akbar, Mamun Al-Mahtab 国际肝胆胰疾病杂志（英文版） . 2013,第004期

3. Etiology, epidemiology, pathology, and advances in diagnosis, vaccine development, and treatment of Gallibacterium anatis infection in poultry: a review [J] . Dharanesha Narasinakuppe Krishnegowda, Kuldeep Dhama, Asok Kumar Mariappan, The Veterinary Quarterly . 2020,第1期

4. Laminosioptes cysticola and Gallibacterium anatis infections in a lymphoma diseased chicken hen with a cystic right oviduct [J] . E. Soriano-Vargas, R. Miranda-Robles, M. C. López-Rosas, Revista Electronica de Veterinaria . 2010,第7期

5. The Fimbrial Protein FlfA from Gallibacterium anatis Is a Virulence Factor and Vaccine Candidate [J] . Ragnhild J. Bager, Barbara Nesta, Susanne E. Pors, Infection and immunity . 2013,第6期

6. Identifying an Immunodominant Epitope of Dengue Non-Structural Protein 1 (NS1) in Acute Secondary Dengue Infections for Vaccine Development or Development of Treatment Modalities [C] . Shyrar Tanussiya Ramu, Dinuka Ariyaratne, Chandima Jeewandara, Conference on From Innovation to Impact . 2020

7. Study of Infection, Immunity, Vaccine and Therapeutics Using Gnotobiotic Pig Models for Human Enteric Viruses. [D] . Yang, Xingdong. 2015

8. Etiology epidemiology pathology and advances in diagnosis vaccine development and treatment of Gallibacterium anatis infection in poultry: a review [O] . Dharanesha Narasinakuppe Krishnegowda, Kuldeep Dhama, Asok Kumar Mariappan, 2020

9. Etiology, epidemiology, pathology, and advances in diagnosis, vaccine development, and treatment of Gallibacterium anatis infection in poultry: a review [O] . Dharanesha Narasinakuppe Krishnegowda, Kuldeep Dhama, Asok Kumar Mariappan, 2020

1. Adhesion of iGallibacterium anatis/ito Chicken Oropharyngeal Epithelial Cells and the Identification of Putative Fimbriae [J] . Mónica L. Salgado Lucio ,Sergio Vaca ,Candelario Vázquez . 微生物学（英文） . 2012,第4期

2. Immunization status and hospitalization for vaccine-preventable and non-vaccine-preventable infections in liver-transplanted children [J] . Palittiya Sintusek ,Yong Poovorawan . 世界肝病学杂志：英文版（电子版） . 2021,第1期

3. HBV vaccine efficacy and detection and genotyping of vaccineé asymptomatic breakthrough HBV infection in Egypt [J] . Eman AE Abushady ,Magda MA Gameel ,John D Klena . 世界肝病学杂志：英文版（电子版） . 2011,第6期

4. 二十八、黄连液加庆大霉素保留灌肠治疗直肠肛门感染性疾病43例 [C] . 杨碧全 . 中国中西医结合学会大肠肛门病专业委员会第九次全国学术会议 . 2003

5. 减毒鼠伤寒沙门氏菌介导的抗原递呈系统在肿瘤治疗性口服DNA疫苗及蛋白质疫苗制备中的应用 [A] . 朱向莹 . 2010